Patients are raising hundreds of thousands of dollars to receive this treatment and they aren't listing $0 in specials revenue. So if patients are paying collectively Millions and we are only noting a fraction of that on the financials then where is the balance going? It is a simple question. On one hand we have Les claiming a sizable jump in patients treated but we show very little on the 10Q. Stop trying to distract this legit question by saying DC-VAX will become new SOC. Yes I agree with that but it has nothing to do with the question at hand. NWBO CEO also manages the private equity firm that owns Advent. Might they be the ones booking the lionshare of the revenue? If so isn't that a conflict of interest?
Market Data 
Markets 
AI
